n African Journal of Psychiatry - Duloxetine as an SNRI treatment for generalized anxiety Disorder (GAD) : results from a placebo and active-controlled trial : product news
|Article Title||Duloxetine as an SNRI treatment for generalized anxiety Disorder (GAD) : results from a placebo and active-controlled trial : product news|
|© Publisher:||In House Publications|
|Journal||African Journal of Psychiatry|
|Publication Date||Mar 2010|
Characterized by persistent, difficult-to-control, chronic worry, GAD is a prominent anxiety disorder owing to its pervasiveness, chronicity, and functional impairment. The underlying neurobiology of GAD suggests involvement of several neurotransmitter systems, including serotonin, norepinephrine, and g-aminobutyric acid (GABA) transmission. In this context, the development of dual-reuptake inhibitors of serotonin and norepinephrine (SNRIs) has been particularly useful and promising for the treatment of GAD.
Article metrics loading...